Prevalence, clinical manifestations, and associated factors of long COVID-19
Prevalencia, manifestaciones clínicas y factores asociados al COVID-19 de larga duración
Keywords:COVID-19, post-acute COVID-19 syndrome, long-COVID
The aim was to describe the prevalence, clinical manifestations, and associated factors of long-COVID. Bibliographic research of systematic reviews and meta-analyses was carried out in MEDLINE (through PubMed) until April 7th, 2022. 37 articles were found and 3 were included. Evidence quality was assessed via AMSTAR 2 criteria. Long-COVID prevalence is 43% (IC95%: 39% – 46%). Main clinical manifestations were weakness (41% [IC95%: 25% – 59%]), malaise (33% [IC95%: 15% – 57%]), fatigue (31% [IC95%: 24% – 39%]), concentration impairment (26% [IC95%: 21% – 32%]), and breathlessness (25% [IC95%: 18% – 34%]). Factors associated with long COVID were female sex, initial disease severity, age, and presence of comorbidities.
How to Cite
Copyright (c) 2022 Revista de la Facultad de Medicina Humana
This work is licensed under a Creative Commons Attribution 4.0 International License.